Sales and Marketing
FDA approves supplemental drug application for Pfizer’s EURCRISA in children with eczema
March 25, 2020 Research and Development, Sales and Marketing eczema, eczema cream, eczema ointment
Demand for hydroxychloroquine soars after Trump says it can treat coronavirus
March 25, 2020 Research and Development, Sales and Marketing COVID-19, Wuhan Coronavirus, china coronavirus, coronavirus, covid19
AstraZeneca to leverage Silence Therapeutics’ siRNA expertise in $480mn deal
March 25, 2020 Research and Development, Sales and Marketing AstraZeneca, Silence Therapeutics, collaboration, pharma
Sustainability and security: How packaging is modernising pharma
March 24, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing counterfeit medicines, falsified medicines, feature, packaging, pharma
FDA turns down label expansion for Jardiance as an adjunct to insulin in type 1 diabetes
March 23, 2020 Sales and Marketing FDA, diabetes, jardiance, pharma
More young coronavirus patients being hospitalised in Europe and US compared to China
March 23, 2020 Sales and Marketing COVID-19, Wuhan Coronavirus, china coronavirus, coronavirus
ViiV Healthcare scores world-first approval in Canada for monthly HIV regimen Cabenuva
March 23, 2020 Sales and Marketing Cabenuva, Canada, HIV, pharma
AI may help predict patient response to non-small cell lung cancer therapies
March 23, 2020 Medical Communications, Sales and Marketing Cancer, Lesions, cancer treatment, tumour treatment
US continues sanctions against Iran despite coronavirus ravaging both nations
March 23, 2020 Manufacturing and Production, Sales and Marketing Iran, Iran US, US, coronavirus
Top Ten most popular articles on Pharmafile.com this week
March 20, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Chinese Coronavirus, Wuhan Coronavirus, china coronavirus, coronavirus
Drug launches across Europe will be affected by coronavirus
March 20, 2020 Medical Communications, Sales and Marketing EU, Europe, coronavirus, pharma
Japan grants orphan drug designation to Lynparza for BRCA+ unresectable pancreatic cancer
March 19, 2020 Research and Development, Sales and Marketing AstraZeneca, Japan, lynparza, pharma
Japan approves Novartis’ Zolgensma for spinal muscular atrophy in patients under two years old
March 19, 2020 Sales and Marketing Japan, Novartis, Zolgensma, pharma, spinal muscular atrophy
Global drug spending projected to reach $1.1 trillion by 2024, report argues
March 18, 2020 Research and Development, Sales and Marketing IQVIA, pharma, report
$63bn Allergan/AbbVie merger review could be delayed by coronavirus
March 18, 2020 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, Allergan, merger, pharma
Latest content
Recruitment experts hired in search for new CGT Catapult chief
Envirogen secures place on NHS Scotland reverse osmosis framework
